Title: Mon-Tarng Chen: Innovator in Cancer Treatment
Introduction
Mon-Tarng Chen is an inventor based in Tainan, Taiwan. He has made significant contributions to the field of biotechnology, particularly in cancer treatment. Although he currently holds no granted patents, his work is noteworthy for its potential impact on medical science.
Latest Patent Applications
Mon-Tarng Chen's latest patent application is titled "Method for Treating a Cancer Associated with the Activation of Galectin-1." This application provides a method for the treatment and/or prophylaxis of cancer associated with galectin-1. The method includes administering a pharmaceutical composition primarily composed of ganoderic acid S (GAS) and ganoderic acid T (GAT). Additionally, it involves administering another anti-cancer agent before, together with, or after the administration of the pharmaceutical composition to synergistically suppress cancer growth.
Conclusion
Mon-Tarng Chen's innovative approach to cancer treatment highlights the importance of ongoing research in biotechnology. His work may pave the way for new therapeutic options in the fight against cancer.